tradingkey.logo
搜索

Propanc Biopharma Ord Shs

PPCB
添加自选
1.941USD
+0.021+1.09%
收盘 11-13 16:00(美东)
2.00M总市值
0.00市盈率 TTM

关于 Propanc Biopharma Ord Shs 公司

Propanc Biopharma, Inc. is an Australia-based biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Propanc Biopharma Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Propanc Biopharma Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
100.00K
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
100.00K
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%

常见问题

Propanc Biopharma Ord Shs的前五大股东是谁?

Propanc Biopharma Ord Shs 的前五大股东如下:Mr. James Andrew Nathanielsz
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有